1-4 of 4
Lu Dai
Close
Sort by
Journal Articles

Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma

Jungang Chen, Navneet Goyal, Lu Dai, Zhen Lin, Luis Del Valle, Jovanny Zabaleta, Jiawang Liu, Steven R. Post, Maryam Foroozesh, Zhiqiang Qin
Journal: Blood
Blood (2020) 136 (19): 2175–2187.
https://doi.org/10.1182/blood.2020005569
Published: 2020
Includes: Supplemental data
Journal Articles

Gambogenic Acid Exerts Antitumor Activity By Mir-21 Regulation in Hypoxic Multiple Myeloma Cells

Ping Liu, MD, Xue Wu, MD, Lu Dai, Zheng Ge, MD PhD, Chong Gao, MD PhD, Hongming Zhang, MD PhD, Fei Wang, MDPhD, Xiaoping Zhang, Bao-An Chen, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5570.
https://doi.org/10.1182/blood.V130.Suppl_1.5570.5570
Published: 2017
Journal Articles

Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma

Lu Dai, Jimena Trillo-Tinoco, Yueyu Cao, Karlie Bonstaff, Lisa Doyle, Luis Del Valle, Denise Whitby, Chris Parsons, Krzysztof Reiss, Jovanny Zabaleta, Zhiqiang Qin
Journal: Blood
Blood (2015) 126 (26): 2821–2831.
https://doi.org/10.1182/blood-2015-07-658823
Published: 2015
Includes: Supplemental data
Journal Articles

Targeting Sphingosine Kinase Induces Apoptosis and Regression Of Virus-Associated Lymphoma In Vivo

Zhiqiang Qin, Lu Dai, Karlie Plaisance-Bonstaff, Can Senkal, Wenxue Wang, Thomas M. Reske, MD, Luis Del Valle, Christina Voelkel-Johnson, Erik Flemington, Besim Ogretmen, Charles D Smith, Chris Parsons
Journal: Blood
Blood (2013) 122 (21): 4414.
https://doi.org/10.1182/blood.V122.21.4414.4414
Published: 2013